By Dr. Jessica Mueller-Albers
Enteric coatings have been utilized with oral drug products for more than 60 years to protect acid-sensitive APIs from gastric acids and prevent gastric irritation by aggressive APIs. However, for many complex drug products targeting the small intestine or ileocolonic region, enteric protection on its own is insufficient to maximize absorption and enhance bioavailability. As a market leader for enteric and other functional coatings for more than 60 years, Evonik has sought to utilize its deep technical expertise to provide a solution to this major unmet industry challenge. This month, Evonik unveiled EUDRATEC® Fasteric as a unique oral drug delivery technology that can provide the answer.